Department of Oncology-Hematology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Department of Pathology, Guglielmo da Saliceto Hospital, Piacenza, Italy.
Anticancer Res. 2014 Sep;34(9):5083-6.
Worldwide, gastric cancer is the fourth most commonly diagnosed type of cancer and the second most common cause of cancer-related death. Recently, it was demonstrated that 15-20% of advanced gastro-oesophageal carcinomas overexpress human epidermal receptor 2 (HER2), one of a family of four identified human epidermal receptors. As in HER2-positive breast cancer, trastuzumab, a monoclonal antibody targeting HER2 receptor, with chemotherapy improves prognosis, time-to-progression and overall survival in patients with advanced gastric cancer. Computed tomography (CT) and ultrasound (US) imaging of gastric cancer has been previously reported, however, to our knowledge HER2-positive gastric adenocarcinoma appearance on US and CT scans has not been previously described and no CT and US images of this variant of adenocarcinoma have been found. We herein report three cases of patients with HER2-positive gastric cancer that showed a marked thickening of the gastric wall on US and CT examination.
在全球范围内,胃癌是第四种最常见的癌症类型,也是癌症相关死亡的第二大主要原因。最近,据证实,15-20%的晚期胃食管腺癌过度表达人表皮受体 2(HER2),这是已鉴定出的四种人表皮受体之一。与 HER2 阳性乳腺癌一样,曲妥珠单抗是一种针对 HER2 受体的单克隆抗体,联合化疗可改善晚期胃癌患者的预后、进展时间和总生存期。之前已经报道了胃癌的计算机断层扫描(CT)和超声(US)成像,但是,据我们所知,HER2 阳性胃腺癌在 US 和 CT 扫描上的表现尚未被描述,也未找到这种腺癌变体的 CT 和 US 图像。我们在此报告三例 HER2 阳性胃癌患者的病例,这些患者在 US 和 CT 检查中胃壁明显增厚。